Teva UK and Others v Gilead Sciences Inc: ECJ 25 Apr 2018

ECJ Patent Law – Supplementary Protection Certificate for Medicinal Products – Opinion – Request for a preliminary ruling – Approximation of laws – Patent law – Supplementary protection certificate for medicinal products – Regulation (EC) No 469/2009 – Article 3(a) – Conditions for obtaining – Product protected by a basic patent in force – Criteria for assessment

Citations:

ECLI:EU:C:2018:278, [2018] EUECJ C-121/17 – O

Links:

Bailii

Jurisdiction:

European

Intellectual Property

Updated: 14 April 2022; Ref: scu.609329